Patients with advanced solid tumors
Conditions
Interventions
None listed
Sponsors
National Cancer Center Hospital
Chugai Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who enrolled into phase I clinical trial in patients with advanced solid tumors (JapicCTI-111490), received RO4987655, and consented to provide archival tumor tissue or biopsy samples.
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of biomarker related to efficacy of RO4987655 | — |
Countries
Japan
Contacts
Public ContactYasuhide Yamada
National Cancer Center Hospital Division of Gastrointestinal Oncology
Outcome results
None listed